Quadrant Capital »

Prime Medicine shares owned by Quadrant Capital

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.7k 966 3.87

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
NVIDIA Corporation (NVDA)
Ishares Core Msci Emkt (IEMG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Target Corporation (TGT)

View all positions for Quadrant Capital

Top funds holding Prime Medicine

Alphabet
Vanguard Group
ARK Investment Management
BlackRock
BlackRock
T. Rowe Price Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Redmile Group
MWG Management
T. Rowe Price Associates
Geode Capital Management
State Street Corporation
Vestal Point Capital
Baker Bros. Advisors

View all funds holding Prime Medicine